Elizabeth Shane
Columbia University · Columbia University Department of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
9
all conditions, ClinicalTrials.gov
NIH grants tied to them
15
1 more share only the name and are not shown
Trial papers
34
PubMed author-name match
Trials
Studies that name Elizabeth Shane as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:48 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04800367 · Romosozumab/Denosumab Study for Premenopausal IOPColumbia University · active not recruiting · Premenopausal Idiopathic Osteoporosis · principal investigator
- Ph2NCT03396315 · Bisphosphonates for Prevention of Post-Denosumab Bone LossColumbia University · completed · IOP, Osteoporosis · principal investigator
- Ph2NCT02049866 · Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOPElizabeth Shane · completed · Adult Idiopathic Generalized Osteoporosis · principal investigator
- Ph2NCT01440803 · Forteo Trial on Idiopathic Osteoporosis in Premenopausal WomenElizabeth Shane · completed · Adult Idiopathic Generalized Osteoporosis · principal investigator
- Ph1/Ph2NCT01375010 · Vitamin D HIV Study on Postmenopausal WomenColumbia University · completed · HIV · principal investigator
- Ph2/Ph3NCT00697463 · Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal WomenColumbia University · completed · Menopause, Fracture, Osteoporosis · principal investigator
- Ph2/Ph3NCT00297830 · Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ TransplantationColumbia University · completed · Heart Transplantation, Liver Transplantation, Bone Resorption · principal investigator
- N/ANCT00005101 · Study of Low Bone Mass in Premenopausal or Perimenopausal WomenNational Center for Research Resources (NCRR) · completed · Osteoporosis · study chair
- Ph3NCT00000412 · Osteoporosis Prevention After Heart TransplantColumbia University · completed · Osteoporosis, Cardiac Transplantation · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Subchondral Trabecular Plate and Rod Abnormalities in Human OsteoarthritisR01AR080135 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2023 to 2024 · $680,608 awarded in 2024Same name and institution; not confirmed by an ID
- Phase 2b Study of Denosumab to Prevent Bone Loss in Idiopathic Osteoporosis in Premenopausal Women Treated with TeriparatideR01FD005114 · FDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2016 to 2019 · $414,452 awarded in 2019Same name and institution; not confirmed by an ID
- Teriparatide for Idiopathic Osteoporosis in Premenopausal Women: A Phase 2 StudyR01FD003902 · FDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2011 to 2019 · $499,998 awarded in 2019Same name and institution; not confirmed by an ID
- Clinical Bone Mechanics Using HR-pQCT R01AR058004 · NIAMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · fiscal years 2010 to 2014 · $487,882 awarded in 2014Same name and institution; not confirmed by an ID
- Idiopathic Osteoporosis in Premenopausal WomenK24AR052665 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2005 to 2014 · $180,809 awarded in 2014Same name and institution; not confirmed by an ID
- Osteoporosis in HIV Infected Postmenopausal WomenR01AI065200 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2005 to 2014 · $710,989 awarded in 2014Grant number is on one of their registry trials
- Ultra-high Resolution pQCT as a Biomarker of Bone Strength in Osteoporosis TrialsU01AR055068 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2007 to 2010 · $81,646 awarded in 2010Same name and institution; not confirmed by an ID
- IDIOPATHIC OSTEOPOROSIS IN PREMENOPAUSAL WOMENR01AR049896 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2005 to 2009 · $575,889 awarded in 2009Same name and institution; not confirmed by an ID
- ZOLEDRONIC ACID IN PROSTATE CANCERM01RR000645 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 1985 to 2005 · $322 awarded in 2005Same name and institution; not confirmed by an ID
- Prevention of Osteoporosis after TransplantationR01AR046124 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 1999 to 2002 · $397,434 awarded in 2002Grant number is on one of their registry trials
- OSTEOPOROSIS AFTER CARDIAC TRANSPLANTATIONR01AR041391 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 1993 to 1997 · $542,091 awarded in 1997Same name and institution; not confirmed by an ID
- CYTOSOL ACTIVATOR OF RAT RETICULOCYTE ADENYLATE CYCLASER01DK031073 · NIDDK · COLUMBIA UNIV NEW YORK MORNINGSIDE · fiscal years 1986 to 1988 · $140,527 awarded in 1988Same name and institution; not confirmed by an ID
- CYTOSOL ACTIVATOR OF RAT RETICULOCYTE ADENYLATE CYCLASEK04DK001334 · NIDDK · COLUMBIA UNIV NEW YORK MORNINGSIDE · fiscal years 1986 to 1987 · $4,572 awarded in 1987Same name and institution; not confirmed by an ID
- CYTOSOL ACTIVATOR OF RAT RETICULOCYTE ADENYLATE CYCLASER01AM031073 · NIADDK · COLUMBIA UNIV NEW YORK MORNINGSIDE · fiscal years 1985 · $64,866 awarded in 1985Same name and institution; not confirmed by an ID
- CYTOSOL ACTIVATOR OF RAT RETICULOCYTE ADENYLATE CYCLASEK04AM001334 · NIADDK · COLUMBIA UNIV NEW YORK MORNINGSIDE · fiscal years 1985 · $54,518 awarded in 1985Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:48 UTC. The ranking covers the 200 most relevant of 34 PubMed records, and a shared surname and initials can bring in a namesake. All 34 on PubMed
- Teriparatide or alendronate in glucocorticoid-induced osteoporosis.N Engl J Med · 2007642 citationsRCR 18.3
- Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate.J Bone Miner Res · 2010225 citationsRCR 7.4
- On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism.J Clin Endocrinol Metab · 1999159 citationsRCR 4.6
- The contribution of testosterone to skeletal development and maintenance: lessons from the androgen insensitivity syndrome.J Clin Endocrinol Metab · 2000121 citationsRCR 3.3
- Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer.J Clin Oncol · 2008119 citationsRCR 3.0
- Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation.N Engl J Med · 2004114 citationsRCR 3.4
- PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism.J Bone Miner Res · 2011105 citationsRCR 3.6
- Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status.Osteoporos Int · 200990 citationsRCR 2.8
- Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism.Ann Intern Med · 198188 citationsRCR 4.3
- Microarchitecture and Peripheral BMD are Impaired in Postmenopausal White Women With Fracture Independently of Total Hip T-Score: An International Multicenter Study.J Bone Miner Res · 201674 citationsRCR 3.9